These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11929820)

  • 1. Tumor genotype-specific growth inhibition in vivo by antisense oligonucleotides against a polymorphic site of the large subunit of human RNA polymerase II.
    Fluiter K; ten Asbroek AL; van Groenigen M; Nooij M; Aalders MC; Baas F
    Cancer Res; 2002 Apr; 62(7):2024-8. PubMed ID: 11929820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A.
    Mook OR; Baas F; de Wissel MB; Fluiter K
    Cancer Gene Ther; 2009 Jun; 16(6):532-8. PubMed ID: 19165236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.
    Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F
    Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    Chavany C; Connell Y; Neckers L
    Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of gene function using C-5 propyne antisense oligonucleotides.
    Flanagan WM; Su LL; Wagner RW
    Nat Biotechnol; 1996 Sep; 14(9):1139-45. PubMed ID: 9631067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.
    Hu Y; Cherton-Horvat G; Dragowska V; Baird S; Korneluk RG; Durkin JP; Mayer LD; LaCasse EC
    Clin Cancer Res; 2003 Jul; 9(7):2826-36. PubMed ID: 12855663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the large subunit of human RNA polymerase II as target for allele-specific inhibition.
    ten Asbroek AL; Fluiter K; van Groenigen M; Nooij M; Baas F
    Nucleic Acids Res; 2000 Mar; 28(5):1133-8. PubMed ID: 10666454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
    Devi GR; Oldenkamp JR; London CA; Iversen PL
    Prostate; 2002 Nov; 53(3):200-10. PubMed ID: 12386920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
    Hatta T; Takai K; Nakada S; Yokota T; Takaku H
    Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumors.
    Lee Y; Vassilakos A; Feng N; Lam V; Xie H; Wang M; Jin H; Xiong K; Liu C; Wright J; Young A
    Cancer Res; 2003 Jun; 63(11):2802-11. PubMed ID: 12782585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calpain-2 as a target for limiting prostate cancer invasion.
    Mamoune A; Luo JH; Lauffenburger DA; Wells A
    Cancer Res; 2003 Aug; 63(15):4632-40. PubMed ID: 12907643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense therapy specific to mutated K-ras gene in hamster pancreatic cancer model. Can it inhibit the growth of 5-FU and MMC-resistant metastatic and remetastatic cell lines?
    Morioka CY; Saito S; Machado MC; Ohzawa K; Kubrusly MS; Cunha JE; Watanabe A
    In Vivo; 2004; 18(2):113-7. PubMed ID: 15113037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphB4 expression and biological significance in prostate cancer.
    Xia G; Kumar SR; Masood R; Zhu S; Reddy R; Krasnoperov V; Quinn DI; Henshall SM; Sutherland RL; Pinski JK; Daneshmand S; Buscarini M; Stein JP; Zhong C; Broek D; Roy-Burman P; Gill PS
    Cancer Res; 2005 Jun; 65(11):4623-32. PubMed ID: 15930280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
    Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
    London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
    Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells.
    Takei Y; Kadomatsu K; Matsuo S; Itoh H; Nakazawa K; Kubota S; Muramatsu T
    Cancer Res; 2001 Dec; 61(23):8486-91. PubMed ID: 11731432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
    Kraemer K; Fuessel S; Schmidt U; Kotzsch M; Schwenzer B; Wirth MP; Meye A
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3794-800. PubMed ID: 14506173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
    Loomis R; Carbone R; Reiss M; Lacy J
    Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.